H&R GmbH & Co. KGaA Reports Preliminary Figures for First Half of 2025

H&R GmbH & Co. KGaA announced preliminary financial results for the first half of 2025, showing stable overall figures. The company reported sales revenues of EUR 653.1 million, slightly down from EUR 675.6 million in the first half of 2024. EBITDA decreased to EUR 40.1 million, compared to EUR 41.1 million last year.

The second quarter witnessed weaker performance with EBITDA at EUR 17.8 million, a drop from EUR 19.8 million in Q2 2024. Sales revenues in Q2 fell to EUR 307.3 million, largely due to lower raw material prices. Earnings before taxes in Q2 were EUR 0.2 million, down from EUR 1.7 million the previous year.

The ChemPharm Refining segment showed improvement with a half-year EBITDA of EUR 26.9 million, compared to EUR 20.6 million in 2024. However, sales in the ChemPharm Sales and Plastics segments declined. Operating cash flow reached EUR 24.6 million for the first half, improving from EUR 5.5 million last year.